Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease defined using a number of well-established molecular subsets. Application of non-negative matrix factorization (NMF) to whole exome sequence data has previously been used to identify six distinct molecular clusters in DLBCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Eugene, Jiang, Yanwen, Xu, Tao, Bazeos, Alexandra, Knapp, Andrea, Bolen, Christopher R., Humphrey, Kathryn, Nielsen, Tina G., Penuel, Elicia, Paulson, Joseph N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892802/
https://www.ncbi.nlm.nih.gov/pubmed/35236331
http://dx.doi.org/10.1186/s12885-022-09237-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892802/
https://www.ncbi.nlm.nih.gov/pubmed/35236331
http://dx.doi.org/10.1186/s12885-022-09237-5

Ejemplares similares